Investment

Details

Screening project between Mitsubishi Tanabe and DNDi
  • RFP Year
    2019
  • Awarded Amount
    $150,000
  • Disease
    NTD (Chagas disease / Leishmaniasis)
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Mitsubishi Tanabe Pharma, Drugs for Neglected Diseases initiative